HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma

Yi-Tuo Xu(Sun Yat-sen University Cancer Center), Jing Xu(University of Chicago)

Biologics

August 1, 2021

10.2147/btt.s325019

Cited by 15

Related Papers

Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma

|Journal of Clinical Investigation|2020|82

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma

|Oncotarget|2015|37

Spatial Organization of Macrophages in CTL-Rich Hepatocellular Carcinoma Influences CTL Antitumor Activity

|Cancer Immunology Research|2025|9

HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides

|Tumor Biology|2014|6

Supplementary Table S4 from Spatial Organization of Macrophages in CTL-Rich Hepatocellular Carcinoma Influences CTL Antitumor Activity

|Unknown|2025|0